The Global Fetal Monitoring Devices market was valued at more than USD 4.62 Billion in 2025, and expected to reach a market size of more than USD 6.86 Billion by 2031 with the CAGR
The global fetal monitoring devices market has been expanding steadily as healthcare systems around the world place greater emphasis on monitoring fetal health throughout pregnancy and labor to improve maternal and neonatal outcomes. Demand for these devices is fundamentally driven by the rising incidence of pregnancy complications such as preterm births, gestational diabetes, hypertension and other conditions that require continuous fetal assessment to ensure the well being of both the mother and the unborn child. Clinicians increasingly rely on fetal monitoring systems in hospitals, maternity clinics and high risk pregnancy care centers to detect early signs of distress, guide obstetric decisions and reduce the likelihood of adverse birth events, which has heightened the importance of effective fetal surveillance in routine obstetric care. According to the Centers for Disease Control and Prevention 2022, congenital heart defects (CHDs) are the most common types of birth defects. The prevalence (the number of babies born with heart defects compared to the total number of births) of some CHDs, especially mild types, is increasing. Also, the prevalence of preterm births is another factor responsible for the use of these fetal monitoring devices. As per WHO 2018, across 184 countries, the rate of preterm birth ranges from 5% to 18% of babies born. Every year, an estimated 15 million babies are born preterm (before 37 completed weeks of gestation), and this number is rising. According to the research report "Global Fetal Monitoring Devices Market Outlook, 2031," published by Bonafide Research, the Global Fetal Monitoring Devices market was valued at more than USD 4.62 Billion in 2025, and expected to reach a market size of more than USD 6.86 Billion by 2031 with the CAGR of 6.97% from 2026-2031. The rise in the premature delivery rate led to the growing need for fetal monitoring equipment. This is expected to contribute to the growing demand for advanced fetal monitoring equipments globally. According to a study published in The Lancet, conducted by researchers from the WHO, the United Nations Children’s Fund (UNICEF), and the London School of Hygiene and Tropical Medicine, in 2020, approximately 13.4 million babies were born prematurely (before 37 weeks of gestation), which represents about 1 in 10 live births globally. With more premature babies being born, Neonatal Intensive Care Units (NICUs) require advanced monitoring equipment systems to manage the health of these vulnerable infants. This is expected to increase the demand for specialized fetal monitors designed for use in NICUs. the availability of refurbished devices puts pressure on manufacturers, limiting their ability to sell new devices at premium prices. Companies like GE Healthcare and Philips face challenges in justifying the premium prices of their advanced devices when more affordable refurbished models are readily available in the market. This price competition is especially intense in emerging markets, where cost is a primary concern, leading to reduced profit margins for manufacturers. This downward pricing pressure, especially in price-sensitive markets, reduces potential profit margins and limits overall market growth for advanced fetal monitoring equipment.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Drivers • Rising prevalence of high risk pregnancies: One of the most significant drivers of the global fetal monitoring devices market is the increasing prevalence of high risk pregnancies and pregnancy related complications such as hypertension gestational diabetes preeclampsia and preterm labor which require continuous and accurate monitoring to ensure maternal and fetal health outcomes. As maternal age rises globally and more women delay childbirth due to career and lifestyle factors, the incidence of complications that can threaten the health of the fetus and mother increases substantially leading healthcare providers to rely heavily on advanced fetal monitoring technologies to detect early warning signs of distress. • Technological advancements: Another powerful driver of market growth is the rapid pace of technological advancements in fetal monitoring devices which are making these systems more accurate, user friendly and accessible. Traditional fetal monitors have evolved significantly with the integration of wireless capabilities artificial intelligence predictive algorithms and telemedicine solutions that allow expectant mothers to be monitored remotely from the comfort of their homes. Portable and wearable fetal monitoring devices are gaining traction because they enable continuous tracking of fetal health parameters without confining women to clinical settings, which is particularly valuable for women in remote areas or with limited access to traditional healthcare facilities. Market Challenges • Stringent regulatory requirements: A major challenge facing the global fetal monitoring devices market is the complex and stringent regulatory environment governing medical devices which varies significantly across regions and can delay product approvals and market entry. Manufacturers must navigate rigorous compliance standards set by health authorities such as the US Food and Drug Administration (FDA) the European Union’s Medical Device Regulation and other national regulatory frameworks to ensure product safety and efficacy before commercialization, which often involves extensive clinical testing documentation and quality management systems. • Limited accessibility in low income regions: Another significant barrier to market growth is the high cost of advanced fetal monitoring devices and the limited accessibility of these technologies in low and middle income regions where healthcare infrastructure may be underdeveloped and budgets constrained. Advanced monitors with wireless connectivity AI analytics and remote capabilities tend to be expensive to procure and maintain, placing them beyond the reach of many smaller hospitals and clinics, particularly in rural and underserved areas. The lack of robust reimbursement policies for fetal monitoring procedures in some countries further exacerbates affordability challenges for patients and healthcare facilities alike, which can lead to lower adoption rates and reliance on traditional or refurbished equipment. Market Trends • Integration of remote monitoring: A key trend shaping the global fetal monitoring devices market is the increasing integration of remote monitoring and telehealth functionalities into monitoring systems which enables expectant mothers to receive continuous fetal health assessments outside traditional clinical environments. Advances in wireless technology coupled with the growing adoption of telemedicine have led to the development of devices that can transmit real time fetal heart rate, movement and other vital data to healthcare providers via cloud based platforms, reducing the need for frequent hospital visits and making prenatal care more convenient and accessible. • Wearable monitoring technologies: Another prominent trend in the fetal monitoring devices market is the growing adoption of artificial intelligence, Internet of Things connectivity and wearable technologies which enhance the capabilities and usability of monitoring systems. Devices incorporating AI algorithms can analyze complex physiological signals with greater accuracy and speed, helping clinicians detect subtle signs of fetal distress and enabling predictive insights that support early intervention. IoT connectivity facilitates seamless data sharing across care teams and integration with electronic medical records, improving clinical workflows and patient management.
| By Product | Ultrasound Devices | |
| Electronic Matermal/Fetal Monitors | ||
| Uterine Contraction Monitor | ||
| Fetal Electrodes | ||
| Fetal Doppler Devices | ||
| Telemetry Devices | ||
| Accessories and Consumables | ||
| Other Products | ||
| By Portability | Non-Portable | |
| Portable | ||
| By Method | Invasive | |
| Non-Invasive | ||
| By Application | Antepartum Fetal Monitoring | |
| Intrapartum Fetal Monitoring | ||
| By End User | Hospitals | |
| Clinics & others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Accessories and consumables are the largest product in the global fetal monitoring devices market because they are essential for every monitoring procedure require frequent replacement and generate continuous recurring demand across clinical settings worldwide. Accessories and consumables include items such as ultrasound gel cables transducers probes electrode belts sensors disposable straps paper charts and other single use or semi durable components that interface directly with the patient and the monitoring system ensuring optimal signal quality and reliable data capture for fetal heart rate uterine contractions and other vital parameters. Because consumables are required for each pregnancy checkup labor monitoring session and prenatal assessment they are continually consumed in high numbers across hospitals clinics and diagnostic centers making them a steady and recurring revenue stream for manufacturers and suppliers whereas the core instruments such as fetal monitors or ultrasounds might be purchased only infrequently and remain in service for many years. Reports indicate that the consumables segment captured the largest share of the market in recent years since ongoing replacement frequency and continuous usage across maternity care facilities significantly outpaces the purchase cycle of instruments which leads to higher aggregate market value for accessories and disposables especially in high patient volume regions. Consumables are fundamental in maintaining hygiene standards and infection control which are critical in obstetric care and thus many healthcare facilities strictly adhere to single use protocols for items like disposable probes and straps further amplifying demand for these products. Non portable fetal monitoring devices are the largest segment in the global fetal monitoring devices market because they provide comprehensive and clinical settings for managing high risk pregnancies. Non portable systems are typically large consoles or cart based monitors that offer advanced multi parameter tracking capabilities, allowing healthcare professionals to continuously observe fetal heart rate, uterine contractions, and other vital indicators with greater accuracy and depth than most portable units can provide. These systems are especially important in scenarios such as high risk pregnancies, complicated labor, cases requiring intrapartum monitoring and when detailed real time data is required to make critical clinical decisions, which is a primary reason these devices are preferentially installed in maternal wards, neonatal intensive care units and labor and delivery rooms across hospitals globally. The robust features of non portable systems, including integration with electronic health record systems, the ability to handle high volume continuous monitoring and advanced analytic tools that assist clinicians in interpreting complex physiological data ensure that they remain indispensable in institutional care settings where patient safety and outcome optimization are priorities. Non portable fetal monitoring systems also tend to support multi parameter assessments and comprehensive data storage, enabling clinicians to review trends over time and facilitate coordinated care planning for both mother and fetus, which is highly valued in structured clinical environments managing large numbers of births and high risk patients. The dominance of this segment is further reinforced by the ongoing global focus on improving maternal and neonatal health outcomes, where stringent clinical protocols call for comprehensive monitoring tools to detect early signs of fetal distress and prevent adverse events, particularly in tertiary care hospitals and referral centers. The non invasive method segment is the largest and fastest growing in the global fetal monitoring devices market because it offers safe comfortable effective and widely accepted monitoring of fetal health without the risks and complications associated with internal procedures. Non invasive monitoring methods rely on external technologies such as ultrasound Doppler and external cardiotocography which can accurately track fetal heart rate uterine contractions and fetal movement without entering the maternal body thus eliminating the risks of infection bleeding or injury that are often associated with invasive procedures like fetal scalp electrodes or intrauterine pressure catheters. This significantly enhances acceptability among expectant mothers and clinicians alike because patient safety and reduced discomfort are major priorities during routine checkups as well as high risk pregnancy management. Clinicians prefer these methods for most prenatal examinations because they provide essential physiological data while maintaining maternal comfort and reducing stress for the patient which encourages repeated use throughout the gestation period and during labor, leading to higher adoption rates in hospitals clinics and outpatient prenatal care facilities globally. The health systems benefit from non invasive methods due to their ability to support frequent and comprehensive assessments without requiring specialized conditions or intensive procedural training which are prerequisites for many invasive approaches. Technological advancements in non invasive fetal monitoring continue to strengthen this segment as well with improvements in ultrasound resolution Doppler sensitivity and wearable external monitoring systems that further enhance diagnostic accuracy and ease of use. These innovations enable more precise fetal assessment, continuous real time monitoring and integration with digital health platforms for remote tracking and data analysis which expands the utility of non invasive devices beyond traditional hospital environments to home care settings and telemedicine driven prenatal programs. Intrapartum fetal monitoring is the largest and fastest growing application in the global fetal monitoring devices market because continuous monitoring during labor and delivery is essential for detecting fetal distress early and reducing maternal and infant complications. Unlike antepartum monitoring which focuses on periodic checks during the prenatal period, intrapartum monitoring is performed continuously as labor progresses and is designed to capture real time physiological metrics such as fetal heart rate patterns, uterine contractions and maternal vital signs that can signal distress conditions including fetal hypoxia, cord compression or uterine hyperstimulation. This continuous surveillance capability is indispensable in modern obstetric practice because it enables clinicians to detect subtle abnormalities as they develop and make urgent decisions about interventions such as assisted vaginal delivery or cesarean section to ensure the safety of both mother and baby. As a result healthcare providers place high priority on intrapartum monitoring systems in hospitals and maternity centers where the bulk of deliveries occur, which greatly drives demand for these devices and cements their leading position within the broader market. The emphasis on intrapartum monitoring has grown alongside increasing global awareness of maternal and neonatal health and a stronger focus on lowering stillbirth and neonatal mortality rates. Hospitals and birthing facilities recognize that continuous monitoring during labor is strongly associated with improved outcomes, particularly for high risk pregnancies complicated by preeclampsia, gestational diabetes, preterm labor, or other clinical conditions that elevate the risk of adverse events during childbirth. Clinicians rely on both traditional electronic fetal monitors and more advanced systems with improved data accuracy to track heart rate variability and uterine activity throughout labor, which helps in quickly identifying fetal distress that might otherwise go unnoticed until it becomes critical. Hospitals are the largest end user segment in the global fetal monitoring devices market because they are the primary care settings where comprehensive maternal and delivery and in high risk pregnancy cases using advanced equipment. Hospitals accommodate a large volume of expectant mothers throughout the entire pregnancy journey from routine checkups to intrapartum monitoring and emergency obstetric care which inherently drives extensive use of fetal monitoring technologies. Hospitals are equipped with advanced diagnostic hardware including non portable cardiotocography systems, high resolution ultrasound machines, integrated monitoring workstations and other comprehensive fetal assessment tools that provide continuous and multi parameter tracking of fetal heart rate uterine activity and other vital signals, enabling clinicians to make timely clinical decisions and intervene when signs of fetal distress or complications arise. These advanced systems are essential in high acuity settings because they deliver accurate real time data that support improved maternal and neonatal outcomes and help reduce risks such as stillbirths and neonatal complications which are particularly prevalent in high risk pregnancies. Hospitals also benefit from substantial healthcare infrastructure investments and budgets that allow them to acquire, maintain and upgrade state of the art fetal monitoring devices and integrate them with hospital information systems for seamless patient data management and clinical workflows which reinforces the preference for institutional adoption over smaller clinics or home care settings. Skilled medical staff including obstetricians, gynecologists, nurses and neonatal specialists is available in hospitals to operate complex monitoring equipment, interpret results and provide immediate clinical responses that are often needed during labor and delivery which further drives reliance on hospital based fetal monitoring.
to Download this information in a PDF
North America is the largest market for global fetal monitoring devices because of its advanced healthcare infrastructure and widespread adoption of cutting edge monitoring technologies supported by favorable regulatory. One of the key drivers of regional dominance is the advanced healthcare infrastructure present throughout the United States and Canada, where large hospital networks, specialized maternity and neonatal care centers and well equipped outpatient facilities support sophisticated maternal and fetal health programs. These facilities routinely use both traditional and state of the art fetal monitoring devices for prenatal care intrapartum surveillance and high risk pregnancy management, ensuring that demand remain consistently high across multiple care settings. Healthcare spending in North America is among the highest globally which enables hospitals and clinics to invest in innovative and high precision fetal monitoring systems that improve clinical outcomes. Hospitals in the region often adopt wireless, non invasive, and smart monitoring technologies early because of better funding, reimbursement coverage, and strong emphasis on patient centric care. The presence of advanced technologies such as remote monitoring, telehealth integration and data driven monitoring platforms further enhances the appeal of these systems among clinicians and patients, driving adoption rates higher than in many other regions. Regulatory bodies like the FDA have established clear guidelines for the approval and safe use of medical monitoring equipment which provides confidence to both healthcare providers and manufacturers. Additionally public and private insurance coverage in the United States and Canada often includes prenatal monitoring services which reduces out of pocket costs for patients and encourages routine use of monitoring devices throughout pregnancy and labor.
to Download this information in a PDF
• February 2025:Huntleigh Healthcare’s Sonicaid Team3 fetal/maternal monitor received FDA 510(k) clearance in February 2025, enabling clinical use in the United States for comprehensive monitoring of maternal and fetal physiological parameters during pregnancy, including support for high‑risk and multi‑fetal cases. • November 2024:Bloomlife secured USD 12.2 million in funding to expand its maternal‑fetal monitoring platform following FDA clearance of its MFM‑Pro wearable device and to accelerate remote monitoring services for high‑risk pregnancies, supporting broader adoption of connected prenatal care tools. • June 2024:Clarius Mobile Health obtained FDA clearance in June 2024 for its OB AI feature integrated into a handheld wireless ultrasound system, leveraging artificial intelligence to automate fetal biometric measurements such as age, weight and growth intervals, which enhances prenatal care accuracy and usability for clinicians including midwives and nurses. • April 2024: GE Healthcare introduced the AI-driven Voluson Signature 20 and 18 ultrasound systems to enhance imaging in women’s health. This launch benefits the fetal monitoring equipment sector by improving the accuracy and efficiency of ultrasound imaging through sophisticated artificial intelligence. • March 2024:Bloomlife partnered with Valley Perinatal Services to implement remote fetal and maternal monitoring combined with clinical alerts to improve early intervention in high‑risk pregnancies, such as those complicated by hypertension and diabetes, enhancing continuous care outside traditional clinical settings. • February 2024: GE Healthcare revealed that its Novii+ Wireless Maternal and Fetal Monitoring Equipment System was able to obtain clearance from the FDA. It can now monitor most of the eligible births in the U.S.
We are friendly and approachable, give us a call.